» Authors » Edward A Gill

Edward A Gill

Explore the profile of Edward A Gill including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 2674
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Altman N, Gill E, Kahwash R, Meyer L, Wagner J, Karimpour-Fard A, et al.
Circ Heart Fail . 2025 Mar; :e012484. PMID: 40052260
Background: Heart rate (HR) affects heart failure outcomes, via uncertain mechanisms that may include left ventricular remodeling. However, in human ventricular myocardium, HR change has not been associated with a...
2.
Martin K, Gill E, Douglas I, Longino A
Ultrasound J . 2025 Jan; 17(1):7. PMID: 39820706
Background: Understanding venous congestion is critical to the management of many illnesses, but assessing volume status can be challenging. The current gold standard for volume status assessment of right heart...
3.
Soszyn N, Gill E, Zablah J, Morgan G
Cardiol Young . 2024 Dec; 34(12):2712-2715. PMID: 39627990
We present the case of 53-year-old woman with a late diagnosis of an right pulmonary artery-left atrium fistula who underwent transcatheter device closure using multi-modality imaging for pre-procedural planning and...
4.
Longino A, Martin K, Leyba K, McCormack L, Siegel G, Sharma V, et al.
Crit Care . 2024 Jun; 28(1):197. PMID: 38858766
Though the novel venous excess ultrasound (VExUS) score is increasingly used as a noninvasive means of venous congestion measurement, the inter-rater reliability (IRR), inter-user reproducibility (IUR), and utility of concurrent...
5.
Koschinsky M, Bajaj A, Boffa M, Dixon D, Ferdinand K, Gidding S, et al.
J Clin Lipidol . 2024 Apr; 18(3):e308-e319. PMID: 38565461
Since the 2019 National Lipid Association (NLA) Scientific Statement on Use of Lipoprotein(a) in Clinical Practice was issued, accumulating epidemiological data have clarified the relationship between lipoprotein(a) [Lp(a)] level and...
6.
Duggal N, Engoren M, Chadderdon S, Rodriguez E, Morse M, Vannan M, et al.
Am J Cardiol . 2023 Dec; 213:99-105. PMID: 38110022
The association, if any, between the effective regurgitant orifice area (EROA) to left ventricular end-diastolic volume (LVEDV) ratio and 1-year mortality is controversial in patients who undergo mitral transcatheter edge-to-edge...
7.
Altman N, Berning A, Mann S, Quaife R, Gill E, Auerbach S, et al.
Circ Res . 2023 May; 132(10):1338-1357. PMID: 37167355
SARS-CoV-2 vaccine-associated myocarditis/myocardial injury should be evaluated in the contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine-associated cardiac disorders. COVID-19 vaccine-associated myocardial injury can be caused...
8.
Altman N, Berning A, Saxon C, Adamek K, Wagner J, Slavov D, et al.
JACC Basic Transl Sci . 2022 Oct; 8(2):124-137. PMID: 36281440
SARS CoV-2 enters host cells via its Spike protein moiety binding to the essential cardiac enzyme angiotensin-converting enzyme (ACE) 2, followed by internalization. COVID-19 mRNA vaccines are RNA sequences that...
9.
Edward J, Chang S, Gill E, Tzou W, Aleong R
JACC Case Rep . 2022 Oct; 4(18):1180-1185. PMID: 36213880
We describe a rare complication of esophago-pericardial fistula after epicardial ventricular tachycardia ablation. Echocardiogram revealed evidence of pneumopericardium and additional imaging studies confirmed esophageal leak with evidence of fistula formation...
10.
Gill E, Nanda N
Echocardiography . 2022 Jul; 39(7):1010. PMID: 35891581
No abstract available.